Lv11
40 积分 2025-11-08 加入
Bayesian Design of Proof-of-Concept Trials
32分钟前
待确认
Miscellanea. Small-sample degrees of freedom with multiple imputation
3小时前
已完结
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
1个月前
已完结
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial
1个月前
已完结
Wilson Confidence Intervals for Binomial Proportions With Multiple Imputation for Missing Data
1个月前
已完结
Backfilling Patients in Phase I Dose-Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
1个月前
已完结
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
2个月前
已完结
Justification for unequal allocation ratios in clinical trials: A scoping review
3个月前
已完结
CLSI POCT05 Performance Metrics for Continuous Interstitial Glucose Monitoring
3个月前
已关闭
皖公网安备34019202002308
